Flutiform Treatment in Patients With Asthma in Daily Clinical Practice; a Prospective Observational Non-interventional Study Assessing the Effect of Space Use and Adherence on Fluticasone/Formoterol FDC Efficacy Measured With the Asthma Control Questionnaire (ACQ-6)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 25 Nov 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Formoterol/fluticasone propionate (Primary)
Indications Asthma
Focus Therapeutic Use
Sponsors Mundipharma Pharmaceuticals BV

Most Recent Events

14 Nov 2018 Planned End Date changed from 1 Nov 2018 to 15 Dec 2016.
14 Nov 2018 Planned primary completion date changed from 1 Mar 2018 to 15 Dec 2016.
14 Nov 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight